Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|April 18, 2013
Determining the optimal time for bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplant in the treatment of multiple myelomaJunru Liu, Juan Li, Beihui Huang, et al.
Zhonghua Nei Ke Za Zhi|January 15, 2015
[Bortezomib-based induction therapy followed by autologous hematopoietic stem cell transplantation in multiple myeloma]Beihui Huang, Juan Li, Junru Liu, et al.
Acta Biochimica Et Biophysica Sinica|December 17, 2009
Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cellsQing Wang, Juan Li, Jingli Gu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 26, 2013
Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantationJuan Li, Junru Liu, Beihui Huang, et al.
Cancer Medicine|February 2, 2021
Comparison of efficacy, safety, patients' quality of life, and doctors' occupational stress between lenalidomide-based and bortezomib-based induction in patients with newly diagnosed multiple myelomaLimei Xu, Junru Liu, Beihui Huang, et al.
Frontiers in Oncology|December 6, 2024
The characteristics of patients with multiple myeloma surviving over 10 yearsBeihui Huang, Hongning Zhang, Junru Liu, et al.
British Journal of Haematology|January 21, 2024
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myelomaHuihui Zhu, Junru Liu, Jingli Gu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 17, 2018
Investigation of the optimal duration of bed rest in the supine position to reduce complications after lumbar puncture combined with intrathecal chemotherapy: a multicenter prospective randomized controlled trialJuan Li, Xiaozhe Li, Xiuzhen Tong, et al.
Biomedicines|January 25, 2025
Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive NomogramYanjuan Li, Lifen Kuang, Beihui Huang, et al.
Medical Oncology (Northwood, London, England)|March 10, 2023
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cellsBeihui Huang, Huixin Liu, Szehoi Chan, et al.
Pageof 5